A review of analytical techniques for characterization of mRNA drug substance in therapeutics and their suitability as a multi-attribute method
Academic source · Discover Pharmaceutical Sciences
Source published:
Site published: 2026-11-03 · Updated: 2026-11-03
This source is linked automatically. Choose a question to get started.
What the paper reports
This review evaluates electrophoresis, chromatography, sequencing, and mass spectrometry for measuring mRNA drug-substance identity, length, concentration, intactness, and purity. It compares throughput, sample preparation, and total analysis time while considering multi-attribute methods used for protein therapeutics. The authors identify opportunities for integrated mRNA analytics, rather than validating a universal platform that replaces all individual quality assays.
Why this paper is included
Provides a framework for reducing analytical burden while requiring explicit evidence of which quality attributes are measured and which risks remain uncovered.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections